Erratum: The preventive effect of pentoxifylline on contrast-induced nephropathy: A randomized clinical trial (Int Urol Nephrol (DOI 10.1007/s11255-013-0420-4));The preventive effect of pentoxifylline on contrast-induced nephropathy: A randomized clinical trial

International Urology and Nephrology

Volumn 46, Issue 1, 2014, Pages 41-46

  Yavari, Vahideh ^a   Ostovan, Mohammad Ali ^a   Kojuri, Javad ^a   Afshariani, Raha ^b   Hamidian, Alireza ^c   Roozbeh, Jamshid ^d   Pakfetrat, Maryam ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Louisiana State University School of Medicine Shreveport   (United States)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Contrast induced nephropathy; Pentoxifylline; Percutaneous coronary intervention

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODIXANOL; PENTOXIFYLLINE; SODIUM CHLORIDE;

ADULT; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; FLUID THERAPY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ACUTE KIDNEY INJURY; ADULT; AMIDOHYDROLASES; CONTRAST MEDIA; FLUID THERAPY; FREE RADICAL SCAVENGERS; HUMANS; HYPERTENSION; MIDDLE AGED; PENTOXIFYLLINE; PERCUTANEOUS CORONARY INTERVENTION;

EID: 84893820691     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0452-9     Document Type: Erratum

References (32)

1. La Manna G, Pancaldi LG, Capecchi A, Maska E, Comai G, Cappuccilli ML, Carretta E, Lombardi A, Colì L, Stefoni S (2010) Risk for contrast nephropathy in patients undergoing coronarography. Artif Organs 34(6):E193-9 (Epub 2010 May)
2. McCullough P (2006) Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67(3):335-343 (Pubitemid 43346729)
3. Friedewald VE, Goldfarb S, Laskey WK, McCullough PA, Roberts WC (2007) The editor's roundtable: contrast-induced nephropathy. Am J Cardiol 100(3):544-551 (Epub 2007 Jun 4) (Pubitemid 47103169)
4. Wu MY, Hsiang HF, Wong CS, Yao MS, Li YW, Hsiang CY, et al (2013) The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials. Int Urol Nephrol. (Epub ahead of print)
5. Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy-a randomized controlled study. Nephrol Dial Transpl 24(10):3103-3107 (Epub 2009 Jun 23)
6. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N et al (2008) Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 300(9):1038-1046
7. Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA (2012) Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Med 125(1):66-78.e3
8. Olin JW, Sealove BA (2010) Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc 85(7):678-692
9. Hansen PR (1994) In vitro studies on responses to pentoxifylline and aminophylline of rat mesenteric resistance vessels. Eur J Pharmacol 261(1-2):105-110 (Pubitemid 24263209)
10. Roozbeh J, HamidianJahromi A, Sharifian M, Pakfetrat M, Afshariani R (2008) Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl 19(6):985-986
11. Luke DR, Berens KL, Verani RR (1989-1990) Role of vascular decongestion in ischemic acute renal failure defined by postinsult administration of pentoxifylline. Ren Fail 11(4):187-94 (Pubitemid 20270794)
12. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ (2011) New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79(1):33-45 (Epub 2010 Sep 22)
13. Ozer MK, Asci H, Oncu M, Yesilot S, Savran M, Bayram D et al (2009) Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats. Ren Fail 31(2):134-139
14. Stojiljkovic N, Veljkovic S, Mihailovic D, Stoiljkovic M, Radenkovic M, Rankovic G et al (2009) Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats. Ren Fail 31(1):54-61
15. Tyagi P, Sharma P, Sharma BC, Puri AS, Kumar A, Sarin SK (2011) Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo. Eur J Gastroenterol Hepatol 23(3):210-217
16. Ozkurkcugil C, Yilmaz MY, Ozkan L, Kokturk S, Isken T (2011) Protective effects of pentoxifylline on cigarette smoking-induced renal tissue damage in rats. Toxicol Ind Health 27(4):335-340 (Epub 2010 Nov 15)
17. Han KH, Han SY, Kim HS, Kang YS, Cha DR (2010) Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy. Inflammation 33(3):137-143
18. Gallardo JM, de Carmen Prado-Uribe M, Amato D, Paniagua R (2007) Inflammation and oxidative stress markers by pentoxifylline treatment in rats with chronic renal failure and high sodium intake. Arch Med Res 38(1):34-38 (Pubitemid 44894622)
19. Escobar J, Pereda J, Arduini A, Sandoval J, Moreno ML, Pérez S et al (2012) Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinol. Biochem Pharmacol 83(1):122-130 (Epub 2011 Oct 8)
20. Renke M, Tylicki L, Rutkowski P, Knap N, Zietkiewicz M, Neuwelt A et al (2010) Effect of pentoxifylline on proteinuria, markers of tubular injury and oxidative stress in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. Acta Biochim Pol 57(1):119-123 (Epub 2010 Mar 22)
21. de Moura FJ, Leal PP, de SouzaFurtado R, Muniz-Junqueira MI, Veiga JP (2008) Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride. Toxicology 243(1-2):66-74. Epub 2007 Oct 7 (Pubitemid 350250960)
22. Wang W, Zolty E, Falk S, Basava V, Reznikov L, Schrier R (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291(5):F1090-5 (Epub 2006 Sep 19) (Pubitemid 44772043)
23. Roozbeh J, Banihashemi MA, Ghezlou M, Afshariani R, Salari S, Moini M et al (2010) Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy. Ren Fail 32(2):172-178
24. Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M (2011) A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. J Pharm Pharm Sci 14(1):128-137
25. Stojiljković N, Veljković S, Mihailović D, Stoiljković M, Ranković G, Jovanović I et al (2009) Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats. Bosn J Basic Med Sci 9(3):239-244
26. Ng YY, Chen YM, Tsai TJ, Lan XR, Yang WC, Lan HY (2009) Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats. Am J Nephrol 29(1):43-53 (Epub 2008 Aug 5)
27. Zhou QG, Zheng FL, Hou FF (2009) Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression. Acta Pharmacol Sin 30(1):98-106 (Epub 2008 Dec 15)
28. Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM (2009) Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial. Am J Kidney Dis 53(4):606-616 (Epub 2009 Feb 12)
29. Firouzi A, Eshraghi A, Shakerian F, Sanati HR, Salehi N, Zahedmehr A, et al (2011) Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients. Int Urol Nephrol [Epub ahead of print]
30. Lee SW, Kim WJ, Kim YH, Park SW, Park DW, Yun SC et al (2011) Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial). Am J Cardiol 107(10):1447-1452 (Epub 2011 Mar 17)
31. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C et al (2008) Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52(8):599-604
32. Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI et al (2006) Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 17(10):2871-2877 (Epub 2006 Aug 23) (Pubitemid 44484677)